Abstract:A novel strain of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) disease (COVID-19) has been recently identified as an infectious disease affecting the respiratory system of humans. This disease is caused by SARS-CoV-2 that was identified in Chinese patients having severe pneumonia and flu-like symptoms. COVID-19 is a contagious disease that spreads rapidly <i>via</i> droplet particles arising through sneezing and coughing action of an infected person. The reports of asymptomatic carriers changed the scenario of symptom based-diagnosis in COVID-19 and intensified the need for proper diagnosis of the majority of the population to combat the rapid transmission of virus. The diagnosis of positive cases is necessary to ensure prompt care to affected people and also to curb further spread of infection in the population. Collecting samples at the right time and from the exact anatomical site is crucial for proper molecular diagnosis. After the complete genome sequence was available, China formulated RT-PCR as a primary diagnostic procedure for detecting SARS-CoV-2. Many in-house and commercial diagnostic kits have been developed or are under development that have a potential to lower the burden of diagnosis on the primary diagnostic techniques like RT-PCR. Serological based diagnosis is another broad category of testing that can detect different serum antibodies like IgG, IgM, and IgA in an infected patient. PCR-based diagnostic procedures that are commonly used for pathogen detection need sophisticated machines and assistance of a technical expert. Despite their reliable accuracy, they are not cost-effective tests, which a common man can afford, so it becomes imperative to look for other diagnostic approaches, which could be cost effective, rapid, and sensitive with consistent accuracy. To make such diagnostics available to the common man, many techniques can be exploited among, which are Point of Care (POC), also known as bed side testing, which is developing as a portable and promising tool in pathogen diagnosis. Other lateral flow assay (LFA)-based techniques like SHERLOCK, CRISPR-Cas12a (AIOD-CRISPR), and FNCAS9 editor-limited uniform detection assay (FELUDA), etc. have shown promising results in rapid detection of pathogens. Diagnosis holds a critical importance in the pandemic situation when there is no potential drug for the pathogen available in the market. This review sums up the different diagnostic approaches designed or proposed to combat the crisis of widespread diagnosis due to the sudden outbreak of a novel pathogen, SARS-CoV-2 in 2019.

Recent advances and perspectives of nucleic acid detection for coronavirus

Nanotechnology-based diagnostic methods for coronavirus: From nucleic acid extraction to amplification

Advancements in Detection Approaches of Severe Acute Respiratory Syndrome Coronavirus 2

Nucleic Acid-Based Diagnostic Tests for the Detection SARS-CoV-2: An Update

Promising methods for detection of novel coronavirus SARS‐CoV‐2

Development of a multi-recombinase polymerase amplification assay for rapid identification of COVID-19, influenza A and B

Nucleic Acid Testing of SARS-CoV-2

Conventional and Microfluidic Methods for the Detection of Nucleic Acid of SARS-CoV-2

Monitoring Coronavirus Disease 2019: A Review of Available Diagnostic Tools

An Update on Molecular Diagnostics for COVID-19

Recent advancements in nucleic acid detection with microfluidic chip for molecular diagnostics

Research progress in laboratory detection of SARS-CoV-2

Recent advances in detection technologies for COVID-19

Nucleic Acid Testing for Coronavirus Disease 2019: Demand, Research Progression, and Perspective

Detection of COVID-19: A review of the current literature and future perspectives

Advancements in Detection of SARS-CoV-2 Infection for Confronting COVID-19 Pandemics

Coronavirus Disease 2019 (COVID-19): Emerging detection technologies and auxiliary analysis

An updated review of SARS-CoV-2 detection methods in the context of a novel coronavirus pandemic

Recent advances in the detection of respiratory virus infection in humans

Recent advances in immunoassay technologies for the detection of human coronavirus infections

Sensitivity evaluation of 2019 novel coronavirus (SARS-CoV-2) RT-PCR detection kits and strategy to reduce false negative